Yoshimura, Takuma https://orcid.org/0000-0001-9919-1692
Nakamura, Kohei https://orcid.org/0000-0002-5162-7132
Chiyoda, Tatsuyuki https://orcid.org/0000-0002-8214-2242
Takamatsu, Reika
Kawano, Ryutaro
Aimono, Eriko
Kawaida, Miho https://orcid.org/0000-0003-0353-4246
Sakai, Kensuke https://orcid.org/0000-0002-1406-086X
Masugi, Yohei https://orcid.org/0000-0002-6952-4043
Nishihara, Hiroshi https://orcid.org/0000-0002-5460-8703
Yamagami, Wataru https://orcid.org/0000-0003-3925-6057
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K21475)
Japan Agency for Medical Research and Development (JP23ck0106872)
Article History
Received: 14 December 2024
Revised: 16 April 2025
Accepted: 18 April 2025
First Online: 20 May 2025
Competing interests
: The authors declare no competing interests.
: This study was approved by the Ethics Committee of Keio University Hospital (approval numbers: 20070081 and 20190111). Written informed consent was obtained from all participants. The study complied with the ethical standards of institutional and national research committees and adhered to the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was given by patients diagnosed with endometrial carcinoma for the use of their samples and information (Keio University Hospital approval number: 20070081). Patients were free to revoke their consent at any time point. In this study, only samples from patients who did not revoke their consent were used.